Skip to content
Wednesday, November 18, 2026
TerraSpinsHub

Individuals Coming Off Anti-Obesity Injections Put On Pounds Far More Rapidly Compared to Those on Conventional Diets

Illustration of pharmaceutical syringe and weighing machine
Weight management involves ongoing approaches.

Fresh analysis suggests that individuals who come off new slimming jabs like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who end traditional diet and exercise programs.

Published data in a major medical journal shows that while overweight people can lose substantial amounts of their body weight while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.

"People using these medications should be informed of the danger of fast weight regain when the medication ends," cautioned lead investigator Dr. Susan Jebb.

Such speed of recovery implies a reversion to original weight within about 18 months.

Analyzing Therapies

The research, which reviewed 37 of studies involving thousands of participants, compared the effects of the injectable medications with conventional dieting.

Researchers emphasize that individuals who shed pounds through lifestyle changes alone usually have a less rapid weight regain—perhaps 100 grams monthly—once they finish.

The Reason for the Fast Rebound

Nutrition scientists suggest the mechanism of the jabs is key to understanding the amplified regain.

The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the system to produce less of its endogenous hormone, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.

"Stopping of this hormone supplement results in appetite is uncontrolled, making binge eating much more probable."

A Chronic Condition?

The NHS suggest the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

Many experts say that, considering the significant potential of relapse, the treatment is often ongoing.

This opinion is echoed by pharmaceutical companies, who note that the findings "highlight the long-term character of excess weight," similar to managing conditions like high blood pressure.

Patient Accounts

Individuals who have stopped the jabs report a intense return of hunger.

"It was like a trigger flipping and you're instantly ravenous," said an individual.

The struggle is exacerbated if users have not adopted sustainable lifestyle or habit changes during therapy.

Growing Use

Recent estimates show that a significant number of adults in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.

  • Use is more common among females compared to males.
  • The middle-aged age group shows the highest usage rates.
  • A large proportion access the drugs through private healthcare rather than public health services.

Ultimately, researchers stress that while GLP-1 drugs are effective tools for weight loss, they are not a magic fix and long-term success hinges on combined behavioural support.

Written by

Jennifer Harrison

Lena is a horticulturist and urban gardener with a passion for sustainable living and native plants.

TerraSpinsHub

Type to search articles.